Philip Hall

Professional Education

Residency: Stanford University Hospital -Clinical Excellence Research Center (2013) CA

Medical Education: Yale University School of Medicine (2010) CT

The Frequency and Severity of Cardiovascular Toxicity From Targeted Therapy in Advanced Renal Cell Carcinoma Patients.
Hall, P. S., Harshman, L. C., Srinivas, S., & Witteles, R. M. (2013). The Frequency and Severity of Cardiovascular Toxicity From Targeted Therapy in Advanced Renal Cell Carcinoma Patients. JACC. Heart failure, 1(1), 72-78.